BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28131440)

  • 1. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
    Moulis G; Lapeyre-Mestre M; Adoue D; Sailler L
    Rev Med Interne; 2017 Jul; 38(7):444-449. PubMed ID: 28131440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
    Weber E; Moulis G; Mahévas M; Guy C; Lioger B; Durieu I; Hunault M; Ramanantsoa M; Royer B; Default A; Pérault-Pochat MC; Moachon L; Bernard N; Bardy G; Jonville-Bera AP; Geniaux H; Godeau B; Cathébras P
    Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
    Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
    Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoepidemiology of Immune Thrombocytopenia: protocols of FAITH and CARMEN studies.
    Moulis G; Sailler L; Adoue D; Lapeyre-Mestre M
    Therapie; 2014; 69(5):437-48. PubMed ID: 25285364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.
    Palandri F; Polverelli N; Sollazzo D; Romano M; Catani L; Cavo M; Vianelli N
    Am J Hematol; 2016 Jun; 91(4):E267-72. PubMed ID: 26799593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
    Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ITP a thrombophilic disorder?
    Rodeghiero F
    Am J Hematol; 2016 Jan; 91(1):39-45. PubMed ID: 26547507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITP and international guidelines: what do we know, what do we need?
    Rodeghiero F; Ruggeri M
    Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study.
    Moulis G; Lapeyre-Mestre M; Montastruc JL; Sailler L
    Autoimmun Rev; 2015 Feb; 14(2):168-73. PubMed ID: 25461471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
    Mazza P; Minoia C; Melpignano A; Polimeno G; Cascavilla N; Di Renzo N; Specchia G
    Ann Hematol; 2016 Jan; 95(2):239-44. PubMed ID: 26596973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.
    Mahévas M; Fain O; Ebbo M; Roudot-Thoraval F; Limal N; Khellaf M; Schleinitz N; Bierling P; Languille L; Godeau B; Michel M
    Br J Haematol; 2014 Jun; 165(6):865-9. PubMed ID: 24725224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older Adults and Immune Thrombocytopenia: Considerations for the Clinician.
    Crickx E; Mahévas M; Michel M; Godeau B
    Clin Interv Aging; 2023; 18():115-130. PubMed ID: 36726813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of multirefractory immune thrombocytopenia].
    Mahévas M; Audia S; Viallard JF
    Rev Med Interne; 2021 Jan; 42(1):46-49. PubMed ID: 33334631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
    Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
    Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New insights into the epidemiology of immune thrombocytopenia in adult patients: Impact for clinical practice].
    Moulis G; Comont T; Adoue D
    Rev Med Interne; 2021 Jan; 42(1):11-15. PubMed ID: 32798089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of splenectomy for immune thrombocytopenic purpura (ITP) in the era of new second-line therapies and in the setting of a high prevalence of HIV-associated ITP.
    Antel KR; Panieri E; Novitzky N
    S Afr Med J; 2015 Apr; 105(5):408-12. PubMed ID: 26242673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.
    Rodeghiero F
    Br J Haematol; 2018 Apr; 181(2):183-195. PubMed ID: 29479668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment.
    Mageau A; Terriou L; Ebbo M; Souchaud-Debouverie O; Orvain C; Graveleau J; Lega JC; Ruivard M; Viallard JF; Cheze S; Dossier A; Bonnotte B; Perlat A; Gobert D; Costedoat-Chalumeau N; Jeandel PY; Dernoncourt A; Michel M; Godeau B; Comont T
    Am J Hematol; 2022 Jan; 97(1):10-17. PubMed ID: 34661954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of ITP and AIHA in CVID: A systematic literature review].
    Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
    Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.
    Moulis G; Palmaro A; Montastruc JL; Godeau B; Lapeyre-Mestre M; Sailler L
    Blood; 2014 Nov; 124(22):3308-15. PubMed ID: 25305203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.